SATT Paris-Saclay
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
86 Rue De Paris, Orsay, Ile-de-France, 9...Phone Number
+33 184000027Website
www.satt-paris-saclay.frRevenue
$5 MillionIndustry
About SATT Paris-Saclay
Is SATT Paris-Saclay your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if SATT Paris-Saclay has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once SATT Paris-Saclay has new funding data
Click to see if SATT Paris-Saclay had a recent Job posting/layoffs
SATT Paris-Saclay, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SATT Paris-Saclay recently announced quarterly report
Check out if SATT Paris-Saclay is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at SATT Paris-Saclay
Product Launch: Get notified when SATT Paris-Saclay launches new products
Recommended Actions
Reach out to Masked Content who joined SATT Paris-Saclay as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
SATT Paris-Saclay is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SATT Paris-Saclay is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SATT Paris-Saclay.
SATT Paris-Saclay Tech Stack
A closer look at the technologies used by SATT Paris-Saclay
Most Recent Scoops
SATT Paris-Saclay News & Media
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and ...
Newly created spin-off of Gustave Roussy and SATT Paris-Saclay specializing in immuno-oncology will exploit hidden genome, also known as dark genome or non-coding genomeIt intends to develop a first vaccine candidate against colorectal cancer and pancreatic cancerAvignon, France, February 2, 2026 – Kahimmune Therape...SATT Paris-Saclay and Valent BioSciences Sign Joint Agreement to Develop Breakthrough Sustainable Biopesticide Technologies
LIBERTYVILLE, Ill.--(BUSINESS WIRE)--In a first of its kind international partnership, SATT Paris-Saclay, the Technology Transfer Accelerator Office of one of the world’s leading innovation clusters, and Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, signed a joint agreement to develop breakthrough sustainable biopesticide technologies for agricultural applications. Utilizing a strategic process, the organizations w
Top Business Services Companies
Frequently Asked Questions Regarding SATT Paris-Saclay
SATT Paris-Saclay invests in disruptive technologies emerging from its research labs to enhance their technological maturity. The company provides support to researchers in defining industrial transfer strategies and offers services for market opportunity studies and IP portfolio analysis. It also caters to companies looking to implement open-innov... Read More